Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation ChimeraLiver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationChimeraHeart TransplantationTransplantation, AutologousLung TransplantationHSC70 Heat-Shock ProteinsStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyCell TransplantationImmunosuppressive AgentsGraft vs Host DiseaseTransplantation, IsogeneicLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationTreatment OutcomeHeart-Lung TransplantationTransplantation ToleranceTissue and Organ ProcurementPeripheral Blood Stem Cell TransplantationFetal Tissue TransplantationTime FactorsLiver FailureImmunosuppressionRetrospective StudiesHistocompatibility TestingSkin TransplantationPostoperative ComplicationsRadiation ChimeraTransplantation, HeterologousWaiting ListsRecurrenceMesenchymal Stem Cell TransplantationHistocompatibilityCorneal TransplantationTissue TransplantationWhole-Body IrradiationHematologic NeoplasmsTacrolimusCyclosporineFollow-Up StudiesCadaverSurvival AnalysisSurvival RateBrain Tissue TransplantationFacial TransplantationDonor SelectionLiver DiseasesOrgan PreservationMice, Inbred C57BLBusulfanTransplantsLeukemiaHLA AntigensKidney Failure, ChronicRecombinant Fusion ProteinsBronchiolitis ObliteransCombined Modality TherapyRisk FactorsLiverAntilymphocyte SerumCell DifferentiationRemission InductionHand TransplantationAnemia, AplasticBlood Group IncompatibilityCytomegalovirus InfectionsAcute DiseaseMycophenolic AcidBone Marrow CellsPostoperative PeriodMyeloablative AgonistsTissue and Organ HarvestingRats, Inbred LewT-LymphocytesChimerismCyclophosphamidePrognosisEnd Stage Liver DiseaseHematopoiesisLiver CirrhosisNeoplasm TransplantationPatient SelectionDisease-Free SurvivalBrain DeathCells, Cultured